Cancer-related stress induces GC excess, subverts anticancer therapy-induced immunosurveillance, and abolishes therapeutic control of tumors by Tsc22d3 upregulation and significant impairment of the antigen presentation pathway (24). This evidence concerns the gene TSC22D3 and cancer.